Supplementary Fig. S6 from The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin
crossref(2023)
摘要
Fig. S6 shows the effect of the combination with suboptimal doses of CPT or AZD5305
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要